Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

09-241 Anti-phospho JAK-2 (Tyr570) Antibody

This Anti-phospho JAK-2 (Tyr570) Antibody is validated for use in WB, WB, WB for the detection of phospho JAK-2 (Tyr570).

Anti-phospho JAK-2 (Tyr570) Antibody MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Signaling Research Sub-Category: Cytokines & Cytokine Receptors Gene Symbol: JAK-2, JTK10 UniProt Number: O60674
09-241
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, R, Eq, Chp, Po, PmWB, WB, WBRbAffinity PurifiedPolyclonal Antibody
Description
Catalogue Number09-241
DescriptionAnti-phospho JAK-2 (Tyr570) Antibody
Alternate Names
  • Janus kinase 2
  • Janus kinase 2 (a protein tyrosine kinase)
  • tyrosine-protein kinase JAK2
Background InformationJAK-2 (Janus Kinase 2) belongs to the emerging family of non-receptor Janus tyrosine kinases, which regulate a spectrum of cellular functions downstream of activated cytokine receptors in the lympho-hematopoietic system. Immunological stimuli, such as interferons and cytokines, induce recruitment of Stat transcription factors to cytokine receptor-associated JAK-2. JAK-2 then phosphorylates proximal Stat factors, which subsequently dimerize, translocate to the nucleus and bind to CIS elements upstream of target gene promoters to regulate transcription. The canonical JAK/Stat pathway is integral to maintaining a normal immune system by stimulating proliferation, differentiation, survival and host resistance to pathogens. Altering JAK/Stat signaling to reduce cytokine induced pro-inflammatory responses represents an attractive target for anti-inflammatory therapies. Within the JAK-2 kinase domain, there is a region that has considerable sequence homology to the regulatory region of the insulin receptor.
References
Product Information
FormatAffinity Purified
Control
  • Transfected HEK293T cell lysates
PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationThis Anti-phospho JAK-2 (Tyr570) Antibody is validated for use in WB, WB, WB for the detection of phospho JAK-2 (Tyr570).
Key Applications
  • Western Blotting
  • Western Blotting
  • Western Blotting
Biological Information
ImmunogenKLH-conjugated linear peptide corresponding to human JAK-2 phosphorylated at Tyr570.
EpitopePhosphorylated Tyr570
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityThis antibody recognizes JAK-2 when phosphorylated on Tyr570.
Species Reactivity
  • Human
  • Rat
  • Horse
  • Chimpanzee
  • Pig
  • Primate
Species Reactivity NoteDemonstrated to react with human and rat. Predicted to react with equine, chimpanzee, porcine, and primate based on 100% sequence homology.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq].
Gene Symbol
  • JAK-2
  • JTK10
Purification MethodAffinity Purfied
UniProt Number
UniProt SummaryFUNCTION:Plays a role in leptin signaling and control of body weight By similarity. Tyrosine kinase of the non-receptor type, involved in interleukin-3 and probably interleukin-23 signal transduction.

CATALYTIC ACTIVITY:ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.

SUBUNIT STRUCTURE: Interacts with SIRPA and SH2B1 By similarity. Interacts with IL23R, SKB1 and STAM2.

SUBCELLULAR LOCATION: Endomembrane system; Peripheral membrane protein By similarity. Note: Wholly intracellular, possibly membrane associated By similarity.

TISSUE SPECIFICITY: Expressed in blood, bone marrow and lymph node.

DOMAIN: Possesses two phosphotransferase domains. The second one probably contains the catalytic domain By similarity, while the presence of slight differences suggest a different role for domain 1.

PTM:Leptin promotes phosphorylation on tyrosine residues, including phosphorylation on Tyr-813 by similarity.

INVOLVEMENT IN DISEASE: Chromosomal aberrations involving JAK2 are found in both chronic and acute forms of eosinophilic, lymphoblastic and myeloid leukemia. Translocation t(8;9)(p22;p24) with PCM1 links the protein kinase domain of JAK2 to the major portion of PCM1. Translocation t(9;12)(p24;p13) with ETV6.Defects in JAK2 are a cause of susceptibility to Budd-Chiari syndrome [MIM:600880]. Budd-Chiari syndrome is a spectrum of disease states, including anatomic abnormalities and hypercoagulable disorders, resulting in hepatic venous outflow occlusion. Clinical manifestations observed in the majority of patients include hepatomegaly, right upper quadrant pain, and abdominal ascites.

Defects in JAK2 are associated with polycythemia vera (PV) [MIM:263300]. PV, the most common form of primary polycythemia, is caused by somatic mutation in a single hematopoietic stem cell leading to clonal hematopoiesis. PV is a myeloproliferative disorder characterized predominantly by erythroid hyperplasia, but also by myeloid leukocytosis, thrombocytosis, and splenomegaly. Familial cases of PV are very rare and usually manifest in elderly patients.

Defects in JAK2 gene may be a cause of essential thrombocythemia (ET) [MIM:187950]. ET is characterized by elevated platelet levels due to sustained proliferation of megakaryocytes, and frequently lead to thrombotic and haemorrhagic complications.

Defects in JAK2 are associated with familial myelofibrosis [MIM:254450]. Myelofibrosis with myeloid metaplasia is a myeloproliferative disease with annual incidence of 0.5-1.5 cases per 100,000 individuals and age at diagnosis around 60 (an increased prevalence is noted in Ashkenazi Jews). Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.

Defects in JAK2 are a cause of acute myelogenous leukemia (AML) [MIM:601626]. AML is a malignant disease in which hematopoietic precursors are arrested in an early stage of development.

SEQUENCE SIMILARITIES:Belongs to the protein kinase superfamily. Tyr protein kinase family. JAK subfamily.

Contains 1 FERM domain.

Contains 1 protein kinase domain.

Contains 1 SH2 domain.
Molecular Weight~ 125 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blot in transfected HEK293T cell lysates.

Western Blot Analysis: 0.05 ug/mL of this antibody detected JAK-2 on 10 µg of transfected HEK293T cell lysates.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
09-241 04053252421518

Documentation

Anti-phospho JAK-2 (Tyr570) Antibody MSDS

Title

Safety Data Sheet (SDS) 

Anti-phospho JAK-2 (Tyr570) Antibody Certificates of Analysis

TitleLot Number
Anti-phospho-JAK-2 (Tyr570) - 2444782 2444782
Anti-phospho-JAK-2 (Tyr570) - 2032272 2032272
Anti-phospho-JAK-2 (Tyr570) - 3211896 3211896
Anti-phospho-JAK-2 (Tyr570) - 3502921 3502921
Anti-phospho-JAK-2 (Tyr570) - 3639491 3639491
Anti-phospho-JAK-2 (Tyr570) - 3821793 3821793
Anti-phospho-JAK-2 (Tyr570) - 3914324 3914324
Anti-phospho-JAK-2 (Tyr570) - 4116907 4116907
Anti-phospho-JAK-2 (Tyr570) - DAM1757710 DAM1757710
Anti-phospho-JAK-2 (Tyr570) -2772645 2772645
Show more

References

Reference overviewPub Med ID
Probiotics down-regulate genes in Salmonella enterica serovar typhimurium pathogenicity islands 1 and 2.
Mohamed A Bayoumi,Mansel W Griffiths
Journal of food protection  73  2009

Show Abstract 		20202329 20202329

Brochure

Title
Pathways and Biomarkers of JAK/STAT Signaling

Technical Info

Title
JAK/STAT Signaling Research Focus

Related Products & Applications

Related Products

Catalogue Number Description
04-001 Anti-JAK2 Antibody, clone 8E10.2
06-255 Anti-JAK2 Antibody
07-606 Anti-phospho-JAK2 (Tyr1007/1008) Antibody
09-275 Anti-phospho-JAK2 (Tyr1007/1008) Antibody
MABS809 Anti-JAK2, clone 1C1 Antibody

Product Families

JAK2 Antibodies and Proteins

Millipore’s JAK2 antibody demonstrates specificity against JAK2, a Janus tyrosine kinase. See below for related products for JAK2, based on the expertise of Upstate & Chemicon.
Learn More >>

Categories

Life Science Research > Antibodies and Assays > Primary Antibodies